Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 111

Vay Sports kicks off with corporate funds

University of Zurich spinout Vay Sports has launched having raised an undisclosed amount from investors including Swisscom and WelcomeAI.

May 7, 2019

Invert Robotics digs in for $8.8m

Inspection robot manufacturer Invert Robotics was founded out of University of Canterbury in 2011 and has now secured corporate Yamaha Motor as an investor in its latest round.

May 7, 2019

UHZ stays fit with Vay Sports

Vay Sports has been spun out of University of Zurich to commercialise a fitness app that exploits computer vision to monitor a user's posture.

May 6, 2019

Corporate venturing deal net: 29 April-3 May 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

May 3, 2019

ClinSpec detects $2.1m

Scottish Investment Bank and Innovate UK were among those backing University of Strathclyde brain cancer diagnosis spinout ClinSpec Diagnostics.

May 2, 2019

UCL helps put Odin Vision in the picture

UCL bowel cancer diagnostics spinout Odin Vision has attracted the UCL Technology Fund in a round that will support trials of its first computer vision-powered product.

Apr 30, 2019

GoLiver goes forth with Satt Ouest Valorisation

Spun out of University of Nantes and research institute Inserm, GoLiver Therapeutics hopes to catalyse a stem cell-based regenerative drug candidate for the treatment of acute and chronic severe liver failure.

Apr 30, 2019

GetYourGuide goes for series E funding

SoftBank is investing an amount reported to be approximately $556m in tour booking service GetYourGuide, though the company itself has not provided confirmation.

Apr 30, 2019

Tencent ventures to Eastern Jinxin

Tencent has provided a nine-figure renminbi sum for Eastern Jinxin as part of a data research and development partnership with its cloud computing subsidiary.

Apr 30, 2019

Navan sups on seed funding

Amgen is among the seed investors for Stanford-licensed drug release technology developer Navan Technologies, which hopes its nanoinjection technique will enable more cell and gene therapies to be produced at scale.

Apr 29, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here